➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Drugs in MeSH Category Topoisomerase II Inhibitors

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics LEVOFLOXACIN levofloxacin TABLET;ORAL 200250-003 Jun 20, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Zydus Pharms LEVOFLOXACIN levofloxacin INJECTABLE;INJECTION 205968-001 Jun 1, 2017 DISCN No No   Start Trial   Start Trial   Start Trial
Larken Labs OFLOXACIN ofloxacin TABLET;ORAL 076093-001 Sep 2, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Actavis Totowa EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 065445-002 Sep 18, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
Watson Labs Inc LEVOFLOXACIN levofloxacin TABLET;ORAL 201484-003 Nov 22, 2013 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.